Abstract:Abstract Aims/hypothesis Transcription factor 7-like 2 (TCF7L2) is a downstream effector of the Wnt/β-catenin signalling pathway implicated in type 2 diabetes risk through genome-wide association studies. Although its expression is critical for adipocyte development, the potential roles of changes in adipose tissue TCF7L2 levels in diabetes risk are poorly defined. Here, we investigated whether forced changes in Tcf7l2 expression in adipocytes affect whole body glucose or lipid metabolism and crosstalk between disease-relevant tissues. Methods Tcf7l2 was selectively ablated in mature adipocytes in C57BL/6J mice using Cre recombinase under Adipoq promoter control to recombine Tcf7l2 alleles floxed at exon 1 (referred to as aTCF7L2 mice). aTCF7L2 mice were fed normal chow or a high-fat diet for 12 weeks. Glucose and insulin sensitivity, as well as beta cell function, were assessed in vivo and in vitro. Levels of circulating NEFA, selected hormones and adipokines were measured using standard assays. Results Reduced TCF7L2 expression in adipocytes altered glucose tolerance and insulin secretion in male but not in female mice. Thus, on a normal chow diet, male heterozygote knockout mice (aTCF7L2het) exhibited impaired glucose tolerance at 16 weeks ( p = 0.03) and increased fat mass (1.4 ± 0.1-fold, p = 0.007) but no changes in insulin secretion. In contrast, male homozygote knockout (aTCF7L2hom) mice displayed normal body weight but impaired oral glucose tolerance at 16 weeks ( p = 0.0001). These changes were mechanistically associated with impaired in vitro glucose-stimulated insulin secretion (decreased 0.5 ± 0.1-fold vs control mice, p = 0.02) and decreased levels of the incretins glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (0.6 ± 0.1-fold and 0.4 ± 0.1-fold vs control mice, p = 0.04 and p < 0.0001, respectively). Circulating levels of plasma NEFA and fatty acid binding protein 4 were increased by 1.3 ± 0.1-fold and 1.8 ± 0.3-fold vs control mice ( p = 0.03 and p = 0.05, respectively). Following exposure to a high-fat diet for 12 weeks, male aTCF7L2hom mice exhibited reduced in vivo glucose-stimulated insulin secretion (0.5 ± 0.1-fold vs control mice, p = 0.02). Conclusions/interpretation Loss of Tcf7l2 gene expression selectively in adipocytes leads to a sexually dimorphic phenotype, with impairments not only in adipocytes, but also in pancreatic islet and enteroendocrine cells in male mice only. Our findings suggest novel roles for adipokines and incretins in the effects of diabetes-associated variants in TCF7L2 , and further illuminate the roles of TCF7L2 in glucose homeostasis and diabetes risk.

Adipose-tissue Treg Cells Restrain Differentiation of Stromal Adipocyte Precursors to Promote Insulin Sensitivity and Metabolic Homeostasis

Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors

Adipose-tissue Regulatory T Cells Are a Consortium of Subtypes That Evolves with Age and Diet.

Two regulatory T cell populations in the visceral adipose tissue shape systemic metabolism

Deciphering visceral adipose tissue regulatory T cells: Key contributors to metabolic health

Adipose tissue regulatory T cells: differentiation and function

Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice

Asc-1 regulates white versus beige adipocyte fate in a subcutaneous stromal cell population

Pleiotropic adipose Treg subsets, defined by Atf3 expression, modulate adipocyte energy expenditure and weight loss

Sex-specific adipose tissue imprinting of regulatory T cells

Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice

Tissue adaptation of regulatory T cells in adipose tissue

Transcriptional and hormonal control of adipose Treg heterogeneity and function

Insulin signaling establishes a developmental trajectory of adipose regulatory T cells

Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential

Discovery of Surrogate Agonists for Visceral Fat Treg Cells That Modulate Metabolic Indices in Vivo.

Loss of ADAM17 from macrophages induces ST2+ T regulatory cells that limit obesity-induced metabolic inflammation in mice through changes in both membrane and soluble TNF

An OGT-STAT5 Axis in Regulatory T Cells Controls Energy and Iron Metabolism

Interferon-α-producing Plasmacytoid Dendritic Cells Drive the Loss of Adipose Tissue Regulatory T Cells During Obesity

Regulatory T cells differentiation in visceral adipose tissues contributes to insulin resistance by regulating JAZF-1/PPAR-γ pathway

Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice